由编辑委员会重点选择放射化学和放射药理学的发展

IF 4.4 Q1 CHEMISTRY, INORGANIC & NUCLEAR

EJNMMI Radiopharmacy and Chemistry Pub Date : 2025-03-25 DOI:10.1186/s41181-025-00335-w

S. Spreckelmeyer, J. Dasilva, C. Decristoforo, R. H. Mach, J. Passchier, G. Carlucci, M. Al Qhatani, A. Duatti, B. T. Cornelissen, J. Engle, A. Denkova, J. J. M. A. Hendrikx, Y. Seimbille, X. Yang, H. Jia, M-R. Zhang, M. Yang, L. Perk, P. Caravan, P. Laverman, Z. Cheng, C. Hoehr, T. Sakr, J. R. Zeevaart

{"title":"由编辑委员会重点选择放射化学和放射药理学的发展","authors":"S. Spreckelmeyer, J. Dasilva, C. Decristoforo, R. H. Mach, J. Passchier, G. Carlucci, M. Al Qhatani, A. Duatti, B. T. Cornelissen, J. Engle, A. Denkova, J. J. M. A. Hendrikx, Y. Seimbille, X. Yang, H. Jia, M-R. Zhang, M. Yang, L. Perk, P. Caravan, P. Laverman, Z. Cheng, C. Hoehr, T. Sakr, J. R. Zeevaart","doi":"10.1186/s41181-025-00335-w","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development and application of radiopharmaceuticals.</p><h3>Main body</h3><p>This selection of highlights provides commentary on 24 different topics selected by each co-authoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.</p><h3>Conclusion</h3><p>Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.</p></div>","PeriodicalId":534,"journal":{"name":"EJNMMI Radiopharmacy and Chemistry","volume":"10 1","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ejnmmipharmchem.springeropen.com/counter/pdf/10.1186/s41181-025-00335-w","citationCount":"0","resultStr":"{\"title\":\"Highlight selection of radiochemistry and radiopharmacy developments by editorial board\",\"authors\":\"S. Spreckelmeyer, J. Dasilva, C. Decristoforo, R. H. Mach, J. Passchier, G. Carlucci, M. Al Qhatani, A. Duatti, B. T. Cornelissen, J. Engle, A. Denkova, J. J. M. A. Hendrikx, Y. Seimbille, X. Yang, H. Jia, M-R. Zhang, M. Yang, L. Perk, P. Caravan, P. Laverman, Z. Cheng, C. Hoehr, T. Sakr, J. R. Zeevaart\",\"doi\":\"10.1186/s41181-025-00335-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development and application of radiopharmaceuticals.</p><h3>Main body</h3><p>This selection of highlights provides commentary on 24 different topics selected by each co-authoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.</p><h3>Conclusion</h3><p>Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.</p></div>\",\"PeriodicalId\":534,\"journal\":{\"name\":\"EJNMMI Radiopharmacy and Chemistry\",\"volume\":\"10 1\",\"pages\":\"\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2025-03-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ejnmmipharmchem.springeropen.com/counter/pdf/10.1186/s41181-025-00335-w\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EJNMMI Radiopharmacy and Chemistry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://link.springer.com/article/10.1186/s41181-025-00335-w\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, INORGANIC & NUCLEAR\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EJNMMI Radiopharmacy and Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.1186/s41181-025-00335-w","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, INORGANIC & NUCLEAR","Score":null,"Total":0}

引用次数: 0

摘要

《EJNMMI放射药学与化学》编委会每两年发布一期重点评论，向读者介绍放射性药物开发和应用领域的最新趋势。这精选的亮点提供了对24个不同主题的评论，这些主题由每个共同撰写的编辑委员会成员选择，涉及从新型放射化学到新型放射性药物的首次人体应用的各种方面。结论放射化学和放射药理学发展趋势突出。热点话题涵盖了EJNMMI放射药学与化学的整个范围，展示了研究领域在许多方面的进展。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Background

The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development and application of radiopharmaceuticals.

Main body

This selection of highlights provides commentary on 24 different topics selected by each co-authoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.

Conclusion

Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

EJNMMI Radiopharmacy and Chemistry Multiple-

CiteScore

7.20

自引率

8.70%

发文量

审稿时长

5 weeks